Physician profile
Morgan Devlin
NPI 1952037004
$1,655.46
in general payments reported to CMS, 2019-2025
19 companies · $605 in 2025
The $605 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $418 · 2024: $632 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,579 · Education: $76.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,579.46 |
| Education | $76.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $318.00 | 2023-2025 | |
| Madrigal Pharmaceuticals | $219.98 | 2025 | Rezdiffra |
| Janssen Scientific Affairs, LLC | $181.91 | 2024 | Stelara |
| Janssen Biotech, INC. | $135.72 | 2023-2025 | Stelara, Tremfya |
| Davol INC. | $123.15 | 2025 | Phasix Mesh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.96 | 2023-2024 | Xifaxan, Trulance |
| Genzyme Corporation | $93.34 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $84.80 | 2023-2024 | Dificid |
| Qol Medical, LLC | $72.65 | 2023-2025 | Sucraid |
| Celgene Corporation | $58.82 | 2023-2024 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $57.17 | 2023-2024 | Entyvio |
| Lilly USA, LLC | $55.81 | 2024-2025 | Omvoh |
| Glaxosmithkline, LLC. | $32.54 | 2024-2025 | Trelegy Ellipta |
| Phathom Pharmaceuticals, INC. | $30.23 | 2024 | Voquezna |
| Acera Surgical, INC. | $20.19 | 2025 | Restrata Wound Matrix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $19.26 | 2025 | Dupixent |
| Exact Sciences Corporation | $18.79 | 2024 | Cologuard Collection Kit |
| Ardelyx, INC. | $18.48 | 2024 | Ibsrela |
| Teleflex LLC | $16.66 | 2025 | Titan Sgs Bailout Chuck |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Devlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.